相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Haploidentical Hematopoietic Cell Transplantation for Myelofibrosis in the Ruxolitinib Era
Massimiliano Gambella et al.
TRANSPLANTATION AND CELLULAR THERAPY (2023)
Impact of donor-derived CD34+infused cell dose on outcomes of patients undergoing allo-HCT following reduced intensity regimen for myelofibrosis: a study from the Chronic Malignancies Working Party of the EBMT
Tomasz Czerw et al.
BONE MARROW TRANSPLANTATION (2022)
Allogeneic blood or marrow transplantation with haploidentical donor and post-transplantation cyclophosphamide in patients with myelofibrosis: a multicenter study
Siddharth Kunte et al.
LEUKEMIA (2022)
Determinants of survival in myelofibrosis patients undergoing allogeneic hematopoietic cell transplantation
Juan Carlos Hernandez-Boluda et al.
LEUKEMIA (2021)
Impact of spleen size and splenectomy on outcomes of allogeneic hematopoietic cell transplantation for myelofibrosis: A retrospective analysis by the chronic malignancies working party on behalf of European society for blood and marrow transplantation (EBMT)
Nicola Polverelli et al.
AMERICAN JOURNAL OF HEMATOLOGY (2021)
Thiotepa-busulfan-fludarabine as a conditioning regimen for patients with myelofibrosis undergoing allogeneic hematopoietic transplantation: a single center experience
Mara Memoli et al.
LEUKEMIA & LYMPHOMA (2021)
Splenectomy before allogeneic hematopoietic cell transplantation for myelofibrosis: A French nationwide study
Jean-Baptiste Bossard et al.
AMERICAN JOURNAL OF HEMATOLOGY (2021)
Thiotepa–busulfan–fludarabine (TBF) conditioning regimen in patients undergoing allogeneic hematopoietic cell transplantation for myelofibrosis: an outcome analysis from the Chronic Malignancies Working Party of the EBMT
Giorgia Battipaglia et al.
BONE MARROW TRANSPLANTATION (2021)
Allogeneic haematopoietic cell transplantation for myelofibrosis: proposed definitions and management strategies for graft failure, poor graft function and relapse: best practice recommendations of the EBMT Chronic Malignancies Working Party
Donal P. McLornan et al.
LEUKEMIA (2021)
Should patients receive consolidation chemotherapy before reduced intensity allogeneic hematopoietic stem cell transplantation for acute myeloid leukemia in first complete remission?
Ja Min Byun et al.
THERAPEUTIC ADVANCES IN HEMATOLOGY (2021)
Pre-hematopoietic cell transplant Ruxolitinib in patients with primary and secondary myelofibrosis
Rachel B. Salit et al.
BONE MARROW TRANSPLANTATION (2020)
The EBMT activity survey on hematopoietic-cell transplantation and cellular therapy 2018: CAR-T's come into focus
Jakob R. Passweg et al.
BONE MARROW TRANSPLANTATION (2020)
Early post-transplantation factors predict survival outcomes in patients undergoing allogeneic hematopoietic cell transplantation for myelofibrosis
Tania Jain et al.
BLOOD CANCER JOURNAL (2020)
Survival following allogeneic transplant in patients with myelofibrosis
Krisstina Gowin et al.
BLOOD ADVANCES (2020)
Australasian Trends in Allogeneic Stem Cell Transplantation for Myelofibrosis in the Molecular Era: A Retrospective Analysis from the Australasian Bone Marrow Transplant Recipient Registry
Yadanar Lwin et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2020)
Myeloablative and Reduced-Intensity Conditioned Allogeneic Hematopoietic Stem Cell Transplantation in Myelofibrosis: A Retrospective Study by the Chronic Malignancies Working Party of the European Society for Blood and Marrow Transplantation
Donal McLornan et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2019)
Family Mismatched Allogeneic Stem Cell Transplantation for Myelofibrosis: Report from the Chronic Malignancies Working Party of European Society for Blood and Marrow Transplantation
Kavita Raj et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2019)
A clinical-molecular prognostic model to predict survival in patients with post polycythemia vera and post essential thrombocythemia myelofibrosis
F. Passamonti et al.
LEUKEMIA (2017)
Allogeneic stem-cell transplantation for myelofibrosis
Noa Lavi et al.
CURRENT OPINION IN HEMATOLOGY (2017)
Use of haploidentical stem cell transplantation continues to increase: the 2015 European Society for Blood and Marrow Transplant activity survey report
J. R. Passweg et al.
BONE MARROW TRANSPLANTATION (2017)
Outcome of Allogeneic Hematopoietic Stem Cell Transplantation for Patients with Chronic and Advanced Phase Myelofibrosis
Alla Keyzner et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2016)
Improved Outcome of Alternative Donor Transplantations in Patients with Myelofibrosis: From Unrelated to Haploidentical Family Donors
Stefania Bregante et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2016)
Incidence and risk factors of poor graft function after allogeneic stem cell transplantation for myelofibrosis
H. Alchalby et al.
BONE MARROW TRANSPLANTATION (2016)
Unrelated donor versus matched sibling donor in adults with acute myeloid leukemia in first relapse: an ALWP-EBMT study
Annalisa Ruggeri et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2016)
ABO blood group mismatched hematopoietic stem cell transplantation
Sibel Akpinar Tekgunduz et al.
TRANSFUSION AND APHERESIS SCIENCE (2016)
Indication and management of allogeneic stem cell transplantation in primary myelofibrosis: a consensus process by an EBMT/ELN international working group
N. M. Kroeger et al.
LEUKEMIA (2015)
CD34+-Selected Stem Cell Boost without Further Conditioning for Poor Graft Function after Allogeneic Stem Cell Transplantation in Patients with Hematological Malignancies
Evgeny Klyuchnikov et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2014)
Reduced-Intensity Hematopoietic Cell Transplantation for Patients with Primary Myelofibrosis: A Cohort Analysis from the Center for International Blood and Marrow Transplant Research
Vikas Gupta et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2014)
CD34 Selected Cells for the Treatment of Poor Graft Function after Allogeneic Stem Cell Transplantation
Alessandra Stasia et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2014)
Allogeneic transplantation for primary myelofibrosis with BM, peripheral blood or umbilical cord blood: an analysis of the JSHCT
M. Murata et al.
BONE MARROW TRANSPLANTATION (2014)
Risk models predicting survival after reduced-intensity transplantation for myelofibrosis
Haefaa Alchalby et al.
BRITISH JOURNAL OF HAEMATOLOGY (2012)
Outcome of Transplantation for Myelofibrosis
Karen K. Ballen et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2010)
A dynamic prognostic model to predict survival in primary myelofibrosis: a study by the IWG-MRT (International Working Group for Myeloproliferative Neoplasms Research and Treatment)
Francesco Passamonti et al.
BLOOD (2010)
Defining the Intensity of Conditioning Regimens: Working Definitions
Andrea Bacigalupo et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2009)
New prognostic scoring system for primary myelofibrosis based on a study of the International Working Group for Myelofibrosis Research and Treatment
Francisco Cervantes et al.
BLOOD (2009)
Allogeneic stem cell transplantation after reduced-intensity conditioning in patients with myelofibrosis: a prospective, multicenter study of the Chronic Leukemia Working Party of the European Group for Blood and Marrow Transplantation
Nicolaus Kroeger et al.
BLOOD (2009)
Characterization of hemopoietic engraftment kinetics and development of secondary cytopenia in AML post auto-SCT and its correlation with survival outcome
A. S. Babatunde et al.
BONE MARROW TRANSPLANTATION (2009)
A retrospective comparison of conventional intensity conditioning and reduced-intensity conditioning for allogeneic hematopoietic cell transplantation in myelofibrosis
V. Gupta et al.
BONE MARROW TRANSPLANTATION (2009)
High antileukemic efficacy of an intermediate intensity conditioning regimen for allogeneic stem cell transplantation in patients with high-risk acute myeloid leukemia in first complete remission
C. Schmid et al.
BONE MARROW TRANSPLANTATION (2008)
Time to engraftment following allogeneic stem cell transplantation is significantly longer in patients with myelodysplastic syndrome than with acute myeloid leukemia
M. Bitan et al.
BONE MARROW TRANSPLANTATION (2008)
Immune hemolysis following ABO-mismatched stem cell or solid organ transplantation
Mark H. Yazer et al.
CURRENT OPINION IN HEMATOLOGY (2007)
ABO blood group barrier in allogeneic bone marrow transplantation revisited
JD Seebach et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2005)
Pilot study of reduced-intensity conditioning followed by allogeneic stem cell transplantation from related and unrelated donors in patients with myelofibrosis
N Kröger et al.
BRITISH JOURNAL OF HAEMATOLOGY (2005)
Allogeneic hematopoietic stem cell transplantation with non-myeloablative conditioning in patients with acute myelogenous leukemia eligible for conventional allografting:: A prospective study
GJ Ruiz-Argüelles et al.
LEUKEMIA & LYMPHOMA (2004)
CD34 cell dose in granulocyte colony-stimulating factor-mobilized peripheral blood mononuclear cell grafts affects engraftment kinetics and development of extensive chronic graft-versus-host disease after human leukocyte antigen-identical sibling transplantation
JM Zaucha et al.
BLOOD (2001)
分享论文
